Michael Ciavarella

Airspace Technologies Announces Strategic Partnership with InVita Healthcare Technologies
to Integrate Blood and Plasma Delivery Data During COVID-19 Crisis and Beyond. Read the original release here.

As more businesses ship goods around the globe, there is a major concern over misrouting. If you are a shipper, the last thing you want is to have your shipments misrouted. This means your customers will have to wait longer for the error to be rectified.  This can lead to a bad reputation in your industry and a loss of business.

As the novel coronavirus (COVID-19) continues to impact our communities, Airspace feels it’s important to share the steps we are taking to ensure that our customers are still receiving the best service to their time-critical shipments. 

The life sciences industry relies heavily on time-critical logistics. Shipments containing blood, tissue, or organs can often mean life or death for the recipient. It is imperative for hospitals, clinics, and specimen banks to effectively plan, route, and track these shipments during this time. 

If the company is Airspace Technologies, nothing.

When managing medical logistics, every minute matters. This is especially true in the medical courier business when an organ or blood donation needs to be delivered across the county or even to a neighboring state.

The life sciences industry relies heavily on time-critical logistics. Shipments containing blood, tissue, or organs can often mean life or death for the recipient. It is imperative for hospitals, clinics, and specimen banks to effectively plan, route, and track these shipments. Shipping medical specimen can be done internally, which can be costly, or through a Third Party Logistics provider. It is imperative for the hospitals or clinics to utilize adaptive technology for added visibility and ease of use.